Literature DB >> 6971877

A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.

M E Pichichero, C B Hall, R A Insel.   

Abstract

The possibility that mucosal antibody is produced as a host response to Haemophilus influenzae type b (Hib) infection was examined in this study. 17 of 18 prospectively evaluated children ranging in age from 2 mo to 7 yr developed a detectable level of anticapsular antibody in their nasopharyngeal secretions after systemic Hib infection. The mean concentration of nasal anti-capsular antibody of the 18 children was 554 ng/mg IgA (SD = 35-8,863) during the acute phase of illness and declined to 224 ng/mg IgA (SD = 19-2,688) in convalescence. Some children had mucosal antibody detectable at least 10 mo after infection. The mucosal antibody levels were not affected by the length of illness before diagnosis, type of disease, age of the patient, sex, or presence of detectable capsular antigen or viable bacteria in the nasopharynx. The mucosal antibody was predominantly of the IgA class and occurred independent of the serum antibody. Six of the children aged less than 1 yr who did not produce and/or sustain a serum antibody level correlated with protection demonstrated a persistent mucosal antibody response. These findings suggest that the mucosal immune system may have the ability to respond at an earlier age than the serum immune system and lead us to postulate that protective secretory antibodies to prevent systemic Hib disease may be inducible in young infants in spite of the poor serum antibody response occurring at this age.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971877      PMCID: PMC370716          DOI: 10.1172/jci110178

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  Salivary immunoglobulin and albumin: development during the newborn period.

Authors:  J C Selner; D A Merrill; H N Claman
Journal:  J Pediatr       Date:  1968-05       Impact factor: 4.406

3.  Observations on neonatal tears.

Authors:  E McKay; H Thom
Journal:  J Pediatr       Date:  1969-12       Impact factor: 4.406

4.  Latex agglutination test for the diagnosis of Haemophilus influenzae meningitis.

Authors:  R B Newman; R W Stevens; H A Gaafar
Journal:  J Lab Clin Med       Date:  1970-07

5.  Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.

Authors:  R Schneerson; L P Rodrigues; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

6.  Mucosal immunity: The origin and migration patterns of cells in the secretory system.

Authors:  T B Tomasi; L Larson; S Challacombe; P McNabb
Journal:  J Allergy Clin Immunol       Date:  1980-01       Impact factor: 10.793

7.  Breast milk antibody to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  M E Pichichero; A E Sommerfelt; M C Steinhoff; R A Insel
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

8.  Concentration of gamma-A-globulin in serum, saliva, and nasopharyngeal secretions of infants and children.

Authors:  J C Haworth; L Dilling
Journal:  J Lab Clin Med       Date:  1966-06

9.  Prevention of bacterial infections of mucosal surfaces by immune secretory IgA.

Authors:  J R Cantey
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

10.  Meningitis caused by Haemophilus influenzae in infant rats: protective immunity and antibody priming by gastrointestinal colonization with Escherichia coli.

Authors:  E R Moxon; P Anderson
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

View more
  10 in total

Review 1.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

2.  Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.

Authors:  M Kauppi-Korkeila; L Saarinen; J Eskola; H Käyhty
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

Review 4.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.

Authors:  A Virolainen; J Jero; H Käyhty; P Karma; J Eskola; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

6.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

7.  Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates.

Authors:  C Bergquist; T Lagergård; M Lindblad; J Holmgren
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Antibody in middle ear fluid of children originates predominantly from sera and nasopharyngeal secretions.

Authors:  Ravinder Kaur; Thomas Kim; Janet R Casey; Michael E Pichichero
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

9.  Mucosal antibody responses are directed by viral burden in children with acute influenza infection.

Authors:  Yong He; Afsheen Abid; Robert Fisher; Nancy Eller; Malgorzata Mikolajczyk; Robert C Welliver; Aleta B Bonner; Dorothy E Scott; Jennifer L Reed
Journal:  Influenza Other Respir Viruses       Date:  2012-03-08       Impact factor: 4.380

10.  Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.

Authors:  Mogens Kilian; Steffen Husby; Jesper Andersen; Zina Moldoveanu; Uffe B Skov Sørensen; Jesper Reinholdt; Hervé Tettelin
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.